Navigation Links
IDEV Technologies Launches Additional Products in Europe

WEBSTER, Texas, Oct. 21 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line. The initial uses of the newly introduced 180mm and 200mm stents occurred in August of this year, followed by a full European market launch at the recent European Society of Vascular Surgery meeting held this past September, in Amsterdam.

SUPERA stents are well known for their radial strength and flexibility that results from the unique wire interwoven nitinol design, which also provides high resistance to kinking/fracturing.  The new 180mm and 200mm sizes are designed for the treatment of long lesions in patients with peripheral vascular disease.

"We are very pleased with the acceptance of these new longer stents.  Our goal is to provide the broadest and most effective line of products for treating patients with peripheral vascular disease.  The successful launch of these additional SUPERA sizes moves us closer to reaching that goal and achieves our objective of launching multiple new products in Europe this year," stated Christopher M. Owens, President and CEO of IDEV.

The launch of these devices follows the recent introduction of the SUPERA VERITAS™ Peripheral Vascular System, an easy to use, reliable and more precise delivery system developed to deliver the SUPERA stent.

Peter Haarbrink, MD, a leading interventional radiologist affiliated with Canisius Wilhelmina Ziekenhuis (CWZ), a large general and teaching hospital located in Nijmegen, The Netherlands, said, "The availability of these new sizes has given me even more options for treating patients with peripheral vascular disease.  The unique and exceptional stent properties, combined with the ease of delivery with the new VERITAS™ system, create a true advancement in technology."

Dierk Scheinert, MD, and Chairman of the Center for Vascular Medicine at the Park Hospital, Leipzig, Germany, was one of the first to deploy the longer sizes.  He concluded, "I've used the SUPERA product for several years and appreciate the ongoing enhancements to the system.  First VERITAS made it easier and more accurate to deploy the stent.  Now the 180mm and 200mm sizes allow me to treat longer and more difficult lesions, they deploy easily and add to a broad stent portfolio."

About IDEV Technologies, IncorporatedIDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology marketplace.  IDEV's worldwide headquarters is located in Webster, Texas and its European headquarters is located in Beuningen, The Netherlands.  Please visit

The SUPERA stent is currently indicated in the US for the palliative treatment of biliary strictures produced by malignant neoplasms and in Europe for both the treatments of biliary strictures produced by malignant neoplasms and for peripheral vascular use following failed percutaneous transluminal angioplasty (PTA).Contact:

William W. BurkeExecutive Vice President & Chief Financial OfficerIDEV Technologies, Incorporated(281) 525-2000Donna LucchesiVice President Global MarketingIDEV Technologies, Incorporated(281) 525-2000

SOURCE IDEV Technologies, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
2. Visonic Technologies Announces the Immediate Availability of its Elpas Door Kit, an All-in-One Starter Kit Packaged With Everything Required to Install a Single-Door Wandering Patient and Resident Protection Solution
3. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
4. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
5. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
6. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
7. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
8. HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
9. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
10. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
11. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
Post Your Comments:
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):